View : 552 Download: 0
JM91, a newly synthesized indoledione derivative, inhibits rat aortic vascular smooth muscle cells proliferation and cell cycle progression through inhibition of ERK1/2 and Akt activations
- Title
- JM91, a newly synthesized indoledione derivative, inhibits rat aortic vascular smooth muscle cells proliferation and cell cycle progression through inhibition of ERK1/2 and Akt activations
- Authors
- Seo J.-M.; Jin Y.-R.; Ryu C.-K.; Kim T.-J.; Han X.-H.; Hong J.-T.; Yoo H.-S.; Lee C.-K.; Yun Y.-P.
- Ewha Authors
- 유충규
- SCOPUS Author ID
- 유충규
- Issue Date
- 2008
- Journal Title
- Biochemical Pharmacology
- ISSN
- 0006-2952
- Citation
- Biochemical Pharmacology vol. 75, no. 6, pp. 1331 - 1340
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- The increased potential for growth of vascular smooth muscle cells (VSMCs) is a key abnormality in the development of atherosclerosis and postangioplasty restenosis. Platelet-derived growth factor (PDGF)-BB is a potent mitogen for VSMCs that plays an important role in the intimal accumulation of VSMCs. This study examined the effect of JM91, a newly synthesized indoledione derivative, on the proliferation of PDGF-BB-stimulated rat aortic VSMCs. The antiproliferative effect of JM91 on rat aortic VSMCs was examined by cell counting and [ 3H]thymidine incorporation assay. The pre-incubation of JM91 (0.5-3.0 μM) significantly inhibited the proliferation and DNA synthesis of 25 ng/mL PDGF-BB-stimulated rat aortic VSMCs in a concentration-dependent manner. JM91 inhibited the PDGF-BB-stimulated phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt kinase, while had no effect on PLCγ1 and PDGF-Rβ activation. In addition, treatment with JM91 (0.5-3.0 μM) induced cell-cycle arrest in the G 1 phase, which was associated with the down-regulation of cyclins and CDKs. These findings suggest that the inhibitory effects of JM91 against proliferation, DNA synthesis and cell cycle progression of PDGF-BB-stimulated rat aortic VSMCs are mediated by the suppression of the ERK1/2 and PI3K/Akt signaling pathways. Furthermore, JM91 may be a potential antiproliferative agent for the treatment of atherosclerosis and angioplasty restenosis. © 2007 Elsevier Inc. All rights reserved.
- DOI
- 10.1016/j.bcp.2007.11.013
- Appears in Collections:
- 약학대학 > 약학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML